Supplements
18
 min read

Should Allergies Be Recorded in Medication Records? UK Guidance Explained

Written by
Bolt Pharmacy
Published on
13/3/2026

Allergies should always be recorded in medication records — this is a non-negotiable element of safe prescribing and medicines management across the NHS. Accurate allergy documentation allows every clinician involved in a patient's care to make informed decisions, reducing the risk of preventable adverse drug reactions. In the UK, incomplete or missing allergy records are a recognised contributor to medication errors, which cause significant patient harm and cost the NHS millions of pounds each year. This article explains what should be documented, who is responsible, what guidance applies, and how both patients and healthcare professionals can ensure allergy information remains accurate and up to date.

Summary: Allergies should always be recorded in medication records, as accurate allergy documentation is essential for safe prescribing and preventing avoidable adverse drug reactions across all NHS care settings.

  • All known drug allergies, hypersensitivity reactions, and intolerances should be documented in a patient's medication record, with details of the reaction, severity, and certainty of the causal link.
  • Where no allergy has been identified, records should explicitly state 'no known drug allergies' (NKDA); an empty allergy field is a patient safety risk.
  • NICE guideline CG183 (Drug allergy: diagnosis and management) is the primary UK guidance on classifying, recording, and acting on drug allergy information.
  • NHS Summary Care Records (SCR) include allergy information as a core dataset, coded using SNOMED CT to ensure interoperability across NHS systems.
  • Responsibility for allergy recording is shared across GPs, hospital prescribers, pharmacists, and patients themselves, with clear processes required at every care transition.
  • Inaccurate or missing allergy records can lead to anaphylaxis, delayed treatment, unnecessary prescribing restrictions, and increased antimicrobial resistance.

Am I eligible for weight loss injections?

60-second quiz
Eligibility checker

Find out whether you might be eligible!

Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).

  • No commitment — just a quick suitability check
  • Takes about 1 minute to complete

Why Allergy Recording in Medication Records Matters

Allergy recording is a patient safety intervention, not merely an administrative task; incomplete records are a recognised contributor to medication errors that cause approximately 1,700 preventable deaths per year in the UK.

Accurate allergy documentation is a fundamental component of safe prescribing and medicines management. When a clinician prescribes a new medication, one of the first checks they perform is a review of the patient's known allergies and adverse drug reactions. Without this information clearly recorded, there is a significant risk that a patient could be prescribed a medicine — or a medicine from the same drug class — that has previously caused them harm.

Allergy recording is not merely an administrative task; it is a patient safety intervention. In the UK, medication errors and avoidable adverse drug reactions remain among the most common causes of preventable harm in healthcare settings. A 2018 report commissioned by NHS England (Elliott RA et al.) estimated that avoidable adverse drug reactions and medication errors contribute to approximately 1,700 deaths per year and cost the NHS around £98 million annually. Incomplete allergy records are a recognised contributing factor to such errors.

It is equally important that allergy status is never left blank in a patient's record. Where no allergy has been identified, this should be recorded explicitly as 'no known drug allergies' (NKDA). Where allergy status has not yet been established, it should be marked as 'unknown' or 'not asked', rather than left empty — an empty field can be misread as meaning no allergies are present, which is a patient safety risk.

Furthermore, allergy information is relevant across the entire care pathway — from a GP surgery to a hospital ward, from a community pharmacist to an urgent care centre. When records are complete and accessible, every clinician involved in a patient's care can make informed, safe prescribing decisions. The Professional Record Standards Body (PRSB) Allergy and Adverse Reaction Information Standard sets out the minimum data items that should be recorded to ensure consistency and interoperability across NHS systems. This is why the question of whether allergies should be recorded in medication records has a clear and unambiguous answer: yes, they absolutely should be.

Requirement What Should Be Recorded Responsible Party Relevant Guidance Risk if Omitted
True allergic reactions (IgE-mediated) Causative agent, reaction type (e.g. anaphylaxis, urticaria), severity, date, certainty GP, hospital prescriber, pharmacist NICE CG183 Anaphylaxis, potentially fatal re-exposure
Severe cutaneous adverse reactions (SCARs) SJS, TEN, DRESS, AGEP — causative agent must be clearly flagged; re-exposure must be avoided Hospital prescriber, GP NICE CG183, MHRA Life-threatening reaction on re-exposure
Non-IgE-mediated hypersensitivity Reaction type and mechanism noted (e.g. NSAID intolerance via COX inhibition) to avoid mislabelling GP, hospital prescriber NICE CG183 Unnecessary prescribing restrictions, broader-spectrum antibiotic use
Intolerances Non-immune adverse effects (e.g. nausea with metformin); recorded separately from true allergy GP, community pharmacist NICE NG5, PRSB Standard Confusion with true allergy; inappropriate prescribing restrictions
No known drug allergies (NKDA) Explicitly record "NKDA"; never leave allergy field blank; unknown status must be marked "not asked" All clinicians at every care setting NICE NG5, NHS SCR guidance Blank field misread as NKDA; patient safety risk
De-labelling after negative drug challenge Removal of allergy label communicated and updated across GP, hospital, and pharmacy records Specialist, GP, pharmacist NICE CG183, NICE NG5 Continued unnecessary antibiotic restrictions; antimicrobial resistance
Coding and interoperability Allergy data recorded using SNOMED CT coding within NHS Summary Care Record (SCR) GP practice, NHS trust IT systems NHS England SCR guidance, PRSB Standard Allergy information unavailable across care settings; medication errors

What Types of Allergies and Reactions Should Be Documented

True IgE-mediated allergies, non-IgE-mediated hypersensitivity, severe cutaneous adverse reactions (SCARs), intolerances, and idiosyncratic reactions should all be documented, with each entry including the causative agent, reaction description, severity, and date.

Not all adverse reactions to medicines are the same, and it is important that documentation reflects the nature and severity of each reaction accurately. Broadly, the following categories should be recorded:

  • True allergic reactions (IgE-mediated hypersensitivity) — immune-mediated responses such as anaphylaxis, urticaria, angioedema, or bronchospasm. Medicines commonly implicated include penicillins, cephalosporins, and neuromuscular blocking agents.

  • Non-IgE-mediated hypersensitivity reactions — these include reactions to NSAIDs such as aspirin, which typically involve non-immune mechanisms (e.g., inhibition of cyclo-oxygenase) rather than true IgE-mediated allergy, and should be documented as such to avoid mislabelling.

  • Severe cutaneous adverse reactions (SCARs) — including Stevens–Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalised exanthematous pustulosis (AGEP). These must be clearly documented and re-exposure to the causative agent avoided; specialist advice should be sought.

  • Intolerances — non-immune-mediated adverse effects that are unpleasant but not life-threatening, such as nausea caused by metformin or headaches from codeine.

  • Idiosyncratic reactions — unpredictable responses that do not follow a clear pharmacological or immunological pattern.

Drug–drug interactions should not be recorded in the allergy field; they should be documented separately under cautions or clinical notes to avoid confusion and mis-documentation.

For each recorded reaction, documentation should ideally include:

  • The name of the causative agent (using the approved generic name where possible, including formulation, route, and any relevant excipients)

  • The nature and description of the reaction

  • Its severity and clinical outcome

  • The date it occurred and the certainty or probability of the causal link

  • Any tolerated alternatives or agents confirmed safe on re-exposure

Distinguishing between a true allergy and an intolerance is clinically important. For example, labelling a patient as 'allergic to penicillin' when they experienced mild nausea may unnecessarily restrict their antibiotic options and lead to the use of broader-spectrum alternatives, contributing to antimicrobial resistance. NICE guideline CG183 (Drug allergy: diagnosis and management) provides detailed guidance on how to classify and document drug reactions appropriately.

Food allergies, latex allergy, and environmental allergies should also be recorded where they are clinically relevant to treatment — for example, a latex allergy is important to note before surgical procedures.

NHS and NICE Guidance on Allergy Documentation

NICE CG183 and NG5, the NHS Summary Care Record, and the PRSB Allergy and Adverse Reaction Information Standard collectively mandate accurate, standardised allergy recording across all NHS care settings.

In the UK, allergy documentation is supported by guidance from several authoritative bodies.

NICE guideline CG183 (Drug allergy: diagnosis and management) is the primary UK guidance on recording, communicating, and acting on drug allergy information. It sets out expectations for documenting the type and severity of reactions, referring patients for specialist allergy assessment where appropriate, and updating records following de-labelling after a negative drug challenge or allergy test.

NICE guideline NG5 (Medicines optimisation: key therapeutic topics) reinforces the importance of maintaining accurate and up-to-date medication records — including allergy status — as part of safe medicines management, and emphasises the need for effective communication of this information at care transitions.

The NHS Summary Care Record (SCR) — an electronic record accessible to authorised NHS clinicians across England — includes allergy and adverse reaction information as a core dataset. NHS England guidance specifies that allergy information should be recorded using standardised coding (SNOMED CT) to ensure consistency and interoperability across systems. This means that when a patient attends a different GP practice, an out-of-hours service, or an emergency department, their allergy information can be retrieved quickly and reliably.

The PRSB Allergy and Adverse Reaction Information Standard defines the minimum data set and structure for allergy and adverse drug reaction recording across NHS systems, supporting safe information sharing between care settings.

The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA) also highlight the importance of adverse drug reaction reporting and documentation as part of pharmacovigilance. At a local level, NHS trusts and integrated care boards are expected to have policies in place that mandate allergy recording as part of the medicines reconciliation process — particularly at points of care transition, such as hospital admission and discharge. Pharmacists, as medicines experts, play a key role in verifying and updating allergy records during medicines reconciliation.

Who Is Responsible for Recording and Updating Allergy Information

Responsibility is shared across GPs, hospital prescribers, community pharmacists, and patients; each has a defined role in recording, verifying, and communicating allergy information, particularly at care transitions.

Responsibility for allergy documentation is shared across the healthcare team, and this shared accountability is a strength of a well-functioning system. However, it also means that clear processes must be in place to avoid gaps.

GPs and primary care teams are typically the first point of contact for allergy recording. When a patient reports a reaction — whether during a consultation, a medication review, or a new patient registration — the GP or practice nurse should document it promptly in the clinical record. Many GP systems will prompt clinicians to record allergy status when issuing a new prescription.

Hospital pharmacists and prescribers are responsible for completing medicines reconciliation on admission, which includes verifying allergy information against the patient's GP record and any information provided by the patient or their carer. Any discrepancies should be resolved and updated in both the hospital and primary care records, in line with NICE NG5.

Community pharmacists are well placed to identify and flag allergy concerns, particularly when dispensing a new medicine or when a patient reports a previous reaction. Community pharmacists record allergy information in the pharmacy medicines record (PMR) and communicate relevant findings to the patient's GP or other care team members; they do not generally have direct editing access to GP or SCR records. Under the NHS Community Pharmacist Consultation Service and other advanced services, pharmacists may communicate allergy information to the wider care team.

Where a patient has undergone specialist allergy assessment or a supervised drug challenge and an allergy label has been removed (de-labelling), it is essential that this is communicated to and updated across all relevant records — including primary care, hospital, and pharmacy records — to ensure the change is reflected consistently wherever the patient receives care.

Ultimately, patients themselves have an important role. Patients should be encouraged to inform every healthcare professional they see of any known allergies or previous adverse reactions, and to carry this information with them — for example, in a medicines list or on a medical alert card.

Risks of Incomplete or Missing Allergy Records

Missing allergy records can cause anaphylaxis, repeated exposure to harmful medicines, delayed treatment, inappropriate prescribing restrictions, and increased antimicrobial resistance — risks that are greatest at points of care transition.

The consequences of missing or inaccurate allergy information can range from mild discomfort to life-threatening harm. The most serious risk is anaphylaxis — a severe, potentially fatal allergic reaction that can occur within minutes of exposure to a known allergen. If a prescriber is unaware of a patient's penicillin allergy, for example, and prescribes amoxicillin, the patient could experience a rapid and dangerous systemic reaction requiring emergency treatment.

Clinicians should also be aware of cross-reactivity within drug classes — for example, between penicillins and other beta-lactam antibiotics. Where allergy status is uncertain for a critical drug class, specialist input should be sought before prescribing, rather than assuming safety.

Beyond acute allergic reactions, incomplete records can lead to:

  • Repeated exposure to a medicine that has previously caused harm, particularly if the patient is seen by a clinician who does not know their history.

  • Delayed treatment — if a clinician is uncertain about a patient's allergy status, they may delay prescribing while seeking clarification, which can be harmful in time-sensitive situations such as infection management.

  • Unnecessary allergy labels — conversely, if a vague or inaccurate allergy is recorded (e.g., 'allergic to all antibiotics'), this can restrict prescribing options inappropriately and lead to suboptimal treatment.

  • Increased healthcare costs and antimicrobial resistance — patients with inaccurate penicillin allergy labels are more likely to receive broader-spectrum antibiotics, which are often more expensive, carry a higher risk of side effects, and contribute to antimicrobial resistance. UK antimicrobial stewardship evidence supports the value of penicillin allergy de-labelling programmes in improving prescribing outcomes.

These risks are compounded at care transitions, where information may not be transferred reliably between settings. Robust allergy documentation, combined with effective medicines reconciliation, is one of the most impactful ways to reduce preventable medication harm.

How to Ensure Your Allergy Information Is Accurate and Up to Date

Patients should maintain a written allergy list and inform all healthcare professionals at every appointment; clinicians should verify and update allergy records at every medicines reconciliation using standardised SNOMED CT coding.

Both patients and healthcare professionals can take practical steps to ensure allergy records are complete, accurate, and accessible.

For patients:

  • Keep a written or digital list of all known allergies and adverse reactions, including the name of the medicine, what happened, and when.

  • Inform every healthcare professional — including dentists, pharmacists, and hospital staff — of your allergies at every appointment.

  • If you believe your allergy record is incorrect or incomplete, contact your GP surgery and ask for it to be reviewed and updated.

  • Consider wearing a medical alert bracelet or carrying a medical alert card if you have a severe or life-threatening allergy, such as anaphylaxis to penicillin. Ensure the information on any alert item is consistent with your GP and hospital records.

  • If you have been told you are allergic to a medicine but have never had a formal assessment, ask your GP whether a referral to a specialist allergy clinic is appropriate. A negative allergy test or supervised drug challenge may allow an inaccurate label to be removed, potentially opening up more effective treatment options.

  • If you think you are having a severe allergic reaction (anaphylaxis): call 999 immediately. If you have been prescribed an adrenaline auto-injector (such as an EpiPen), use it without delay. Lie down with your legs raised unless you are having difficulty breathing. Follow the guidance of the emergency services. (Resuscitation Council UK, Emergency treatment of anaphylaxis.)

  • Suspected adverse reactions to medicines can be reported directly by patients via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk). Your report helps to monitor the safety of medicines in the UK.

For healthcare professionals:

  • Ask about allergies at every new consultation and at medicines reviews, and document responses using standardised coding (SNOMED CT) where possible, in line with the PRSB Allergy and Adverse Reaction Information Standard.

  • Distinguish clearly between allergies, hypersensitivity reactions, and intolerances in the record, and include details of the reaction, its severity, certainty, and outcome.

  • During medicines reconciliation at care transitions, verify allergy information with the patient and cross-reference with existing records, in line with NICE NG5.

  • Where a patient has undergone allergy assessment or a drug challenge and an allergy label has been removed, update all relevant records promptly and communicate this across care settings.

  • If a patient reports a new suspected adverse reaction, consider whether it should be reported via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk). Both healthcare professionals and patients can submit reports, which contribute to ongoing pharmacovigilance and medicines safety monitoring.

  • Where allergy status is uncertain — particularly for high-risk drug classes such as beta-lactam antibiotics — refer to NICE CG183 for guidance on assessment, testing, and de-labelling pathways, and consider referral to a specialist allergy clinic.

Frequently Asked Questions

Should allergies be recorded in medication records even if the reaction was mild?

Yes — all allergies and adverse reactions should be recorded in medication records, regardless of severity, but the nature and severity of the reaction must be clearly documented alongside the entry. Distinguishing a mild intolerance from a severe allergic reaction is clinically important, as it affects future prescribing decisions and avoids unnecessarily restricting treatment options.

What happens if my allergy is recorded incorrectly in my NHS records?

If your allergy information is incorrect, contact your GP surgery and ask for the record to be reviewed and updated. In some cases, your GP may refer you to a specialist allergy clinic for formal assessment or a supervised drug challenge, which can confirm or remove an inaccurate allergy label — potentially opening up more effective treatment options.

Can a pharmacist update my allergy record in my GP notes?

Community pharmacists record allergy information in their own pharmacy medicines record (PMR) but do not generally have direct editing access to GP or NHS Summary Care Records. However, pharmacists can and should communicate allergy concerns to the patient's GP or wider care team, who can then update the primary care record accordingly.

What is the difference between a drug allergy and a drug intolerance, and does it matter which is recorded?

A drug allergy involves an immune-mediated reaction — such as anaphylaxis or urticaria — whereas a drug intolerance is a non-immune adverse effect, such as nausea or headache. Recording the correct distinction matters because mislabelling an intolerance as an allergy can unnecessarily restrict prescribing options and contribute to antimicrobial resistance by prompting the use of broader-spectrum alternatives.

Are allergies shared between my GP, hospital, and pharmacy automatically in the NHS?

Allergy information recorded in your GP record is included in your NHS Summary Care Record (SCR), which can be accessed by authorised NHS clinicians across England, including hospital staff and some pharmacists. However, records are not always updated automatically across all settings, which is why medicines reconciliation — verifying allergy information at every care transition — is a critical safety step.

How do I report a suspected allergic reaction to a medicine in the UK?

Suspected adverse reactions to medicines can be reported directly by patients and healthcare professionals via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. If you experience a severe allergic reaction such as anaphylaxis, call 999 immediately and use your adrenaline auto-injector if one has been prescribed — reporting to Yellow Card can be done afterwards once you are safe.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Book a discovery call

and discuss your eligibility for the Fella Program

Book your free call